- 商品介绍
- 规格参数
- 包装参数
General description
Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.
PPAEC have been used in a pioneer study of endothelial cell motility, where it was determined that asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide production and a cardiovascular risk factor, decreased PKG-mediated phosphorylation of VASP, leading to downregulation of Rac1 and induction of stress fibers and focal adhesions via RhoA/ROCK dependent mechanism, leading to decreased cell motility, and increase in endothelial permeability, thus linking vascular repair and function with NO production (Wojciak-Stothard, 2007, 2009). PPAEC were also used to assess endothelial adhesion to decellularized porcine arteries in order to develop grafts for human vascular repair (Xiong, 2013).
Application
cardiovascular function, screening of drug candidates, angiogenesis, vasodilator function, transport of deoxygenated bloood from heart to lungs
Biochem/physiol Actions
Artery
Preparation Note
Please refer to the PPAEC Culture Protocol.
- 1st passage, >500,000 cells in Porcine Endothelial Cell Growth Medium that contains 10% FBS and 10% DMSO
- Can be cultured at least 16 doublings
Other Notes
Porcine Endothelial Cell Growth Medium that contains 10% FBS and 10% DMSO
| biological source | Porcine pulmonary artery (Normal healthy) |
| Quality Segment | 100 |
| form | solid |
| packaging | pkg of 500,000 cells |
| manufacturer/tradename | Cell Applications, Inc |
| growth mode | Adherent |
| karyotype | 2n = 38 |
| morphology | Endothelial |
| technique(s) | cell culture | mammalian: suitable |
| relevant disease(s) | diabetes; cardiovascular diseases |
| shipped in | dry ice |
| storage temp. | −196°C |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |




微信小程序
7X24小时在线咨询